KOBAYASHI PHARMACEUTICAL CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of KOY for the last quarter is 223.41 M EUR, and it's 35.97% lower compared to the previous quarter. The net income of Q1 24 is 5.98 M EUR.